H-ras Oncogene Mutation and Human Papillomavirus Infection in Oral Carcinomas

Archives of Otolaryngology--Head and Neck Surgery

Volumn 120, Issue 7, 1994, Pages 755-760

  Anderson, Jennifer A ^a,b   Irish, Jonathan C ^a,b,d,e   Mclachlin, C Margaret ^a,c   Ngan, Bo Y ^a,c,f  

^a Departments of Otolaryngology ^*  (United States)

^b Departments of Pathology ^*  (United States)

^c Departments of Pathology   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e Toronto General Hospital   (United States)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; ONCOGENE H RAS; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION SITE; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; VERRUCOUS CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; CARCINOMA, VERRUCOUS; COCARCINOGENESIS; DATA COLLECTION; DNA, VIRAL; HUMAN; MASS SCREENING; MIDDLE AGE; MOUTH NEOPLASMS; NEOPLASM STAGING; PAPILLOMAVIRUS, HUMAN; PAPOVAVIRIDAE INFECTIONS; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTO-ONCOGENE PROTEIN P21(RAS); RISK FACTORS; SURVIVAL RATE; TRANSFECTION; TUMOR VIRUS INFECTIONS;

EID: 0028278057     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archotol.1994.01880310059011     Document Type: Article

References (23)

1. Yasumoto S, Burkhardt AL, Doniger J, et al. Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells. J Virol. 1986;57:572-577.
2. Kaur K, McDougall JK. HPV-18 immortalization of human keratinocytes. J Virol. 1988;62:610-613.
3. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327:293-297.
4. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the pancreas contain mutant c-K-ras genes. Cell. 1988; 53:549-554.
5. Kraus MH, Yuasa Y, Aarsonson SA. A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Proc Natl Acad Sci U S A. 1984;81:5284-5388.
6. Theillet C, Lidereau R, Escot C, et al. Loss of c-H-ras-1 allele and aggressive human primary breast carcinomas. Cancer Res. 1986;46:4776-4781.
7. Barbacid M. Ras genes. Annu Rev Biochem. 1987;56:779-827.
8. Murray MJ, Cunningham JM, Parada LF, et al. The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hemopoietic tumors. Cell. 1983;33:749-757.
9. Dipaolo JA, Woodsworth CD, Popescue VC, Notario V, Doniger J. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene. 1989;4:395-399.
10. Shirasawa H, Tomita Y, Fuse A, et al. Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas. J Gen Virol. 1987;68:583-591.
11. Phelps WE, Yee CL, Munger K, Howley PM. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell. 1988;53:539-547.
12. Hunter T. Cooperation between oncogenes. Cell. 1991;64:249-270.
13. Jiang W, Weinstein Bl. Rapid detection of ras oncogenes in human tumors. Amplifications. 1990;1:22-26.
14. Anderson JA, Irish JC, Ngan BY. Prevalence of ras oncogene mutation in head and neck carcinomas. J Otolaryngol. 1992;21:321-326.
15. Manos M, Ting Y, Lewis A, Broker T, Wolinsky S. Use of the polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cell. 1989;7:209-214.
16. Capon DJ, Chen EY, Levinson AD, Seeburg PH, Goeddel DV. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature. 1983;302:33-37.
17. Krengel U, Schlichting I, Scherer A, et al. Three dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules. Cell. 1990;62:539-548.
18. Kumar R, Sukumar S, Barbacid M. Activation of ras oncogenes preceding the onset of neoplasia. Science. 1990;248:1101-1104.
19. Balmain A, Brown K. Oncogene activation in chemical carcinogenesis. Adv Cancer Res. 1988;51:147-182.
20. Riou G, Barrois M, Sheng M, Duvillard P, L'homme C. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene. 1988;3: 329-333.
21. Furuuta Y, Shinohara T, Sano K, Nagashima K. Molecular pathologic study of human papillomavirus in squamous cell carcinoma of the nasal cavities and paranasal sinuses. Laryngoscope. 1990;101:79-82.
22. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg. 1989;115:621-625.
23. Fliss D, Noble-Topham SE, McLachlin CM, et al. Laryngeal verrucous carcinoma: a clinicopathological study and detection of human papilloma virus using polymerase chain reaction. Laryngoscope. In press.